A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2001
11/21/2001	EP1156119A2 Anti-cancer gene therapy by modulation of immune or inflammatory response
11/21/2001	EP1156118A1 Virus vector
11/21/2001	EP1156111A1 Chimeric arterivirus-like particles
11/21/2001	EP1156102A1 Immunodeficiency virus recombinant poxvirus vaccine
11/21/2001	EP1156061A1 Reagent for the diagnosis of rheumatoid arthritis
11/21/2001	EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001	EP1155322A1 COMPOUNDS AND METHODS FOR THE DETECTION AND PREVENTION OF $i(T. CRUZI) INFECTION
11/21/2001	EP1155119A1 Bhv-1 gene-deleted virus vaccine
11/21/2001	EP1155037A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses
11/21/2001	EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
11/21/2001	EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001	EP1154793A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
11/21/2001	EP1154792A2 Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant
11/21/2001	EP1154791A2 Neisserial vaccine compositions and methods
11/21/2001	EP1154790A2 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
11/21/2001	EP1154789A2 Caulobacter lps immunoadjuvant
11/21/2001	EP1154785A2 Inhibitors for use in hemostasis and immune function
11/21/2001	EP1154691A1 Targeted transscleral controlled release drug delivery to the retina and choroid
11/21/2001	EP1154686A1 Method for inhibiting transplant rejection
11/21/2001	EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001	EP0810877B1 Hepatitis b vaccine
11/21/2001	EP0773962B1 Antibodies which activate an erythropoietin receptor
11/21/2001	EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors
11/21/2001	EP0722317B1 Liposomes containing particulate materials
11/21/2001	EP0646243B1 Detection of alzheimer's disease and amyotrophic lateral sclerosis using a photoaffinity labeling method
11/21/2001	CN1323346A TPL-2/COT kinase and methods of use
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323223A Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
11/21/2001	CN1323222A LT and CT in parenteral immunization methods against helicobacter infection
11/21/2001	CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
11/21/2001	CN1323217A Methods for therapeutic vaccination
11/21/2001	CN1323213A Blood-brain barrier therapeutics
11/21/2001	CN1322762A Humanized antibody with specificity to HBV surface antigen PRE-S1 and its producing process
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/20/2001	US6320036 GbpA
11/20/2001	US6320033 Nucleotide sequence for use in the prevention, diagnosis and treatment of microorganismal infection
11/20/2001	US6320030 Mucin-biomolecules complex for transfection
11/20/2001	US6320027 Polypeptide for use in the detection of preferential viral diseases
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319714 Generating genetically engineered nucleotide sequences; mix primers, polymerase, and separate nucleotide sequences, incubate, add ligase, recover genetically engineered products
11/20/2001	US6319709 Tumor cells with increased immunogenicity and uses therefor
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319675 Methods for detecting and/or identifying agents which bind and/or modulate function of “bonzo” chemokine receptor
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319666 Treating humans for viral infections; incubate human with antigen, monitor immunological response, screen for presence of viral proteins
11/20/2001	US6319518 Colon selective drug delivery composition
11/20/2001	US6319505 Administering to patient suffering from tardive dyskinesia effective amount of botulinum toxin selected from types c, e, and g, thereby alleviating symptoms
11/20/2001	US6319503 Fusion protein comprising ubiquitin fused to single epitope-containing segment comprising two or more identical epitopes, wherein segment is not cleaved from protein by exposure to ubiquitin-specific proteases; immunogens
11/20/2001	US6319502 Immunogenic polypeptide; treating malaria
11/20/2001	US6319501 Vaccine comprising hepatitis b virus surface antigen having sequence (ctkpsdgnc) within residues s(139-147) and at least one non-permitted variant of said surface antigen
11/20/2001	US6319499 Administering amount of antibody or fragment thereof effective to activate endogenous activity of erythropoietin receptor in mammal, wherein antibody or fragment thereof interacts with peptide consisting of specified amino acid sequence
11/20/2001	US6319498 Amyloidogenic protein, or fragment thereof, modified with cis-decalin group, cholanoyl structure, cholyl group, diethylenetriaminepentaacetyl group, menthoxyacetyl group, fluorescein-containing group, or n-acetylneuraminyl group
11/20/2001	US6319496 Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
11/20/2001	CA2089753C Interleukin-2-leukotoxin gene fusions and uses therefor
11/20/2001	CA2084521C Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method
11/20/2001	CA2065022C Rubella peptides
11/19/2001	CA2324167A1 A membrane-bound netrin
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001	CA2477192A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/15/2001	WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085972A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085949A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection
11/15/2001	WO2001085947A2 Compounds and methods for the diagnosis and treatment of babesia microti infection
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085927A1 Malaria vaccine and methods thereof based upon novel antigenic domain of plasmodium falciparum
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085919A1 Hiv-producing cell line and use thereof
11/15/2001	WO2001085911A2 Chromosome 17p-linked prostate cancer susceptibility gene and a paralog and orthologous genes
11/15/2001	WO2001085904A2 A novel polypeptide--- a human protein 9 containing the fragment of prion characteristic sequence and polynucleotide encoding it
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085777A2 Therapeutic pore-forming peptides
11/15/2001	WO2001085774A1 A probiotic adhesin product, derived from lactobacillus
11/15/2001	WO2001085773A2 Luxo-sigma54 interactions and methods of use
11/15/2001	WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001	WO2001085771A1 Novel ttv-related virus s-ttv
11/15/2001	WO2001085770A2 Sentinel virus ii
11/15/2001	WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001	WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001	WO2001085208A2 Molecular antigen arrays and vaccines
11/15/2001	WO2001085207A2 Modulation of antigen processing using phagocytic cells
11/15/2001	WO2001085205A1 Compositions and methods for induction of active autoimmunity
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells

1 ... 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 ... 1823